The Sticky Truth

FDA Scrutiny on Honey Fraud Intensifies

The U.S. Food and Drug Administration (FDA) recently released findings from its latest honey sampling assignment, reaffirming a persistent issue in the food industry: economically motivated adulteration (EMA). Honey remains particularly vulnerable to this form of food fraud, where cheaper sweeteners—such as sugarcane or corn syrups—are added without disclosure.

How the FDA Tests for Adulteration

To detect adulteration, the FDA uses stable carbon isotope ratio analysis. This scientific method compares the carbon isotope profile of a honey sample with that of its naturally occurring proteins. Authentic honey has a predictable isotopic signature; deviations may indicate the presence of added sugars. When inconsistencies arise, the FDA conducts further evaluation, accounting for natural compositional variation and testing tolerances before determining whether a product is violative.

The Buzz: What the FDA Found, Low but Notable Violation Rates

In 2025, the FDA tested 102 honey samples—54 domestic and 48 imported. The results showed a violation rate of approximately 4% across both categories, with two violative samples identified in each group.

While relatively low, these findings are consistent with prior FDA sampling efforts:

2022–2023: 3% violation rate among 107 imported samples
2021–2022: 10% violation rate among 144 imported samples

The data suggests some improvement over time, though the risk of adulteration remains.

The Legal Sticky Point: Regulatory Response and Enforcement

When adulterated honey is identified, the FDA takes targeted enforcement actions. Imported products may be placed on import alerts, effectively preventing their entry into the United States. For domestic products, the agency works with manufacturers on recalls and corrective measures to address compliance issues.

Why This Matters (Beyond Your Morning Toast)

Although most honey tested in 2025 met authenticity standards, the FDA’s findings underscore an important reality: honey continues to be a high-risk product for food fraud. For producers, importers, and distributors, this means:

Maintaining rigorous supply chain verification practices
Implementing robust testing and quality assurance protocols
Staying informed about evolving FDA surveillance and enforcement trends

The FDA has indicated it will continue monitoring honey through risk-based sampling programs and pursue follow-up actions where necessary.

Bottom Line

Even with relatively low violation rates, the economic incentives behind honey adulteration ensure that it remains an enforcement priority. Companies operating in this space should treat compliance not as a one-time requirement, but as an ongoing risk management strategy.

For more information on FDA’s regulation of honey or other questions on FDA regulatory compliance and enforcement issues, please email info@garg-law.com.